Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefu Zhuyu Capsule for post-thoracoscopic chest pain in early NSCLC
ChiCTR2100051270Phase 4Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of xuefu zhuyu in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Peking University People's Hospital. Primary endpoints: Effective rate of pain improvement, Cough score and 2 more. Started Sep 2021; status: recruiting.
02
Drugs
xuefu zhuyu
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2100051270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051270.